Sevoflurane reduces clinical disease in a mouse model of multiple sclerosis.
about
Plasma kynurenic acid concentration in patients undergoing cardiac surgery: effect of anaesthesia.Inhibitory effects of propofol on Th17 cell differentiation.Immune Modulation by Volatile AnestheticsEffects of peptide fraction and counter ion on the development of clinical signs in experimental autoimmune encephalomyelitis.Inhibition of autoimmune Th17 cell responses by pain killer ketamine.Volatile Anesthetics and Immunity.
P2860
Sevoflurane reduces clinical disease in a mouse model of multiple sclerosis.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Sevoflurane reduces clinical disease in a mouse model of multiple sclerosis.
@ast
Sevoflurane reduces clinical disease in a mouse model of multiple sclerosis.
@en
type
label
Sevoflurane reduces clinical disease in a mouse model of multiple sclerosis.
@ast
Sevoflurane reduces clinical disease in a mouse model of multiple sclerosis.
@en
prefLabel
Sevoflurane reduces clinical disease in a mouse model of multiple sclerosis.
@ast
Sevoflurane reduces clinical disease in a mouse model of multiple sclerosis.
@en
P2093
P2860
P356
P1476
Sevoflurane reduces clinical disease in a mouse model of multiple sclerosis.
@en
P2093
Anthony J Sharp
David E Schwartz
Douglas L Feinstein
Guy Weinberg
Israel Rubinstein
Paul E Polak
Randall O Dull
Richard Ripper
Sergey Kalinin
P2860
P2888
P356
10.1186/1742-2094-9-272
P577
2012-12-19T00:00:00Z
P5875
P6179
1041337434